Troy Bremer, PhD
Founder & Chief Scientific Officer of PreludeDx
| 0:00 | Welcome, Introductions, and Agenda |
| 2:02 | Introduction to DCISionRT |
| 5:58 | DCISionRT Validation Data Review |
Pat Whitworth, MD, FACS
Breast Surgical Oncology Specialist, Director of the Nashville Breast Center
| 10:15 | Standard of Care for DCIS |
| 12:06 | DCISionRT Correctly Reclassifies Patient Risk |
| 14:27 | Surgical Perspective on Clinical Impact of DCISionRT |
Chirag Shah, MD
Director of Clinical Research & Associate Professor in the Department of Radiation Oncology at the Cleveland Clinic
| 17:46 | DCISionRT Helps to Tailor Individual Radiation Treatment Decisions |
| 20:06 | DCISionRT Minimizes Over & Under Treatment |
| 22:14 | Clinical Implications of DCISionRT for Radiation Oncologists |
Anne Peled, MD
Co-Director, Sutter CPMC Breast Cancer Program
| 23:39 | Clinical Application of DCISionRT |
| 27:40 | Oncoplastic Case Studies |
| 33:16 | Clinical Considerations & Benefits of DCISionRT |
Karen Barbosa, DO, FACOS
Breast Surgeon, Oncoplastic Surgeon, & Medical Director of Tidal Health Delaware Breast Cancer Program
| 35:38 | Incorporating DCISionRT into a Health System |
Panel Discussion
| 38:46 | What are the important considerations when utilizing DCISionRT? |
| 41:26 | Ordering DCISionRT on lumpectomies & biopsies |
| 44:07 | How to use DCISionRT in your surgical practice |
| 47:15 | How do surgical margins apply to radiation oncology? |
| 53:47 | Endocrine therapy for DCIS |
| 56:51 | Patient risk tolerance |